Cita APA (7a ed.)
Deng, J., Heybati, K., Ramaraju, H. B., Zhou, F., Rayner, D., & Heybati, S. (2023). Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: A systematic review and network meta-analysis. Infection, 51(1), 21-36.
Cita Chicago Style (17a ed.)
Deng, Jiawen, Kiyan Heybati, Harikrishnaa Ba Ramaraju, Fangwen Zhou, Daniel Rayner, y Shayan Heybati. "Differential Efficacy and Safety of Anti-SARS-CoV-2 Antibody Therapies for the Management of COVID-19: A Systematic Review and Network Meta-analysis." Infection 51, no. 1 (2023): 21-36.
Cita MLA (9a ed.)
Deng, Jiawen, et al. "Differential Efficacy and Safety of Anti-SARS-CoV-2 Antibody Therapies for the Management of COVID-19: A Systematic Review and Network Meta-analysis." Infection, vol. 51, no. 1, 2023, pp. 21-36.
Precaución: Estas citas no son 100% exactas.